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Abstract 
Naloxone hydrochloride, popularly known by the brand name Narcan, is an emergency 
treatment used to reverse an overdose on opioid drugs. The CDC reports upwards of 26,000 
individuals saved by naloxone between 1996 and 2014 (Centers for Disease Control and 
Prevention, 2015). Despite this success rate, those outside of the medical field largely remain 
unaware of what naloxone is or how they can use it in an emergency, leading to needless loss of 
life. Many studies focusing on naloxone access and education have been unable to offer findings 
meant to increase the use and ownership of the drug by lay individuals. To help redress this, the 
current study aims to dissect the potential motivations and deterrents to accessing and acquiring 
naloxone using the Health Belief Model as a guide. Participants were asked to complete a survey 
investigating their previous exposure to, general attitudes about, and intent to access and further 
educate themselves about naloxone. The current study seeks to utilize the motivational 
framework of the Health Belief Model to better understand the important issue of access to anti-
opioid drugs. Relevant findings are intended to aid in the pursuit of an efficient and successful 
application in the public health domain to increase naloxone possession and decrease deaths 
caused by opioid drugs.   
Keywords: Health Belief Model (HBM), overdose, drugs, naloxone, public health, opioid 
crisis, motivation, health behavior   
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Naloxone Education and the Health Belief Model 
Naloxone hydrochloride, commonly known by the brand-name Narcan, is an anti-opioid 
drug used in the treatment of opiate overdose cases. Narcan has the ability to “reverse the effects 
of opioids, including respiratory depression, sedation, and hypotension” (Endo Pharmaceuticals, 
2004). This drug is often used by medical personnel and first responders to resuscitate patients in 
emergency situations. While Narcan is commonplace in the medical field, awareness is not as 
wide-spread within the American public.  
There are many medications that the general population lacks awareness of without 
consequence; what makes Narcan any different? It is available in most states without a 
prescription, meaning that the public has the unique opportunity to play a part in the reversal of 
opioid overdoses. Furthermore, medical doctors have voiced their support of public access to 
Narcan and see it as an effective, practical treatment for overdose cases (Behar, Bagnulo, & 
Coffin, 2018). Despite this opportunity to safely treat and protect members of the community, 
many Americans remain unaware of how to obtain and administer Narcan.  
The lack of knowledge about anti-opioid drugs is particularly concerning in light of the 
ongoing opioid epidemic in the United States. Starting in 2016, the sale and use of drugs such as 
heroin, fentanyl, and tramadol began to rise. The next year saw a significant increase in opioid-
induced fatalities in 23 states (CDC, 2018). Nearly half the states in the country experienced 
extreme and dangerous changes due to the heightened availability of opioid drugs, prompting the 
U.S. Surgeon General to release an official advisory “emphasizing the importance of the 
overdose-reversing drug naloxone.” While opioid overdoses and related deaths remain at an all-
time high, as outlined below, the American public remains largely unaware of what Narcan is 
and how it could be used to save a life.     
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The lack of public knowledge regarding Narcan has been demonstrated in both popular 
and empirical research. A 2018 IBM Watson study boasts knowledge of the drug in nearly 60% 
of participants, however, the focus should be shifted to the significantly lower figures of those 
who have purchased the drug and are aware that it does not require a prescription in most states. 
Roughly 30% of participants were aware that Narcan could be obtained prescription-free at the 
pharmacy. This figure is a closer approximation of individuals who are informed enough to 
acquire Narcan. The distinction between awareness of the drug and knowledge of how to get it 
becomes important when observing the probability of collecting and eventually administering 
Narcan. An empirical study sponsored by the National Institutes of Health (NIH) also collected 
similar results. Approximately 65% of participants knew what Narcan/naloxone was, but 
knowledge of where to acquire the drug was significantly lower (33%) (Kirane, Ketteringham, 
Bereket, Dima, Basta, Mendoza, & Hansen, 2016). These studies are extremely helpful in 
identifying the gaps in public education and groups that are most in need of an intervention. 
While research has also identified a shortage in pharmacist and health provider knowledge about 
naloxone (See Nielsen, Menon, Larney, Farrell, & Degenhardt, 2016; Kirane et al., 2016), the 
current study aims to focus on the health behaviors of the general population.  
Vulnerable populations and monetary barriers have been a subject of study in many 
research projects concerning anti-opioid drugs. A 2018 study from the University of Pittsburgh 
School of Nursing provided Narcan administration training and prescriptions for each 
participant. All participants in the study were patients at a clinic for the homeless, a population 
that is “disproportionately affected by opioid overdoses” (Pietrusza, Puskar, Ren, & Mitchell, 
2018). The study reported a statistically significant increase in participant knowledge of signs of 
opioid overdose, how to respond to an overdose, and how to deliver a nasal dosage of Narcan. 
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While the improvement in education is promising, the researchers also report that only 33% 
percent of study participants filled the Narcan prescription in the subsequent week. This low fill-
rate emphasizes the need to explore the logistical and psychological influences that prevent 
individuals from acquiring Narcan.  
The current study is critical because it addresses and seeks to understand an issue that has 
been largely ignored thus far in psychological literature. It will not only identify the contributing 
factors of low levels of naloxone education, but also to provide an understanding of the social 
influences that shape these contributors. Additionally, this study will culminate in the 
development of future directions for anti-opioid awareness efforts. The ultimate goal of this 
study is to increase the health behaviors of possessing and knowing how to use drugs like Narcan 
to reduce deaths caused by opioid overdose.    
The Health Belief Model (HBM) 
The Health Belief Model (HBM) seeks to determine the likelihood of practicing health 
behaviors through the observation of various psychological dimensions. Rosenstock, Strecher, 
and Becker break down the HBM into a triad of factors including: relevancy of the health issue, 
perceived threat, and likelihood of success (Becker, Drachman, & Kirscht, 1974). A 
comprehensive review of HBM academic literature published in 1984 reconfigures these 
categories in the now commonly used dimensions of perceived susceptibility, perceived severity, 
perceived benefits, and perceived barriers. Subsequent alterations of the HBM in later research 
have also emphasized the role of self-efficacy in determining an individual’s health beliefs 
(Glanz & Bishop, 2010). The four HBM dimensions established in Janz and Becker’s decade-
spanning meta-analysis in addition to self-efficacy will be used to guide the current research 
(Figure 1). All of these perceptions converge to motivate or inhibit a person’s practiced health 
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behaviors—including the decision to acquire naloxone. Let us move on to see how these factors 
can motivate or prevent someone from taking action in this context. 
Figure 1 
Health Belief Model Conceptualization for Acquiring Naloxone 
 
Perceived Severity 
 Beliefs about the severity of an opioid is individually variable. Those who perceive this 
event as having severe consequences on their health, safety, or social life may be more 
incentivized to take preventative action. However, if an individual does not believe an opioid 
overdose has severe and adverse consequences, they may not be motivated to proactively prevent 
an overdose. 
Perceived Susceptibility 
Some individuals may not take steps to prevent opioid overdoses because they are not 
addicted to opioid drugs. This perception can also extend to their social circles, such as friends, 
family members, and neighbors that the individual assumes are unaffected by opioid use.  
Perceived Benefits 
Perceived benefits to action can assist in motivating a health behavior. These benefits 
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may be personal, for instance, owning naloxone may be advantageous to an individual’s own 
health and safety. Benefits can also be more broad, including results such as the betterment of 
society or the protection of a friend or family member. The benefits of the drug itself would also 
be considered—does it effectively treat the issue? Will it help the person it is given to? Perceived 
benefits should outweigh perceived barriers in the pursuit of a health behavior.  
Perceived Barriers 
Additionally, the negative stigmas regarding drug-users, lack of access to a pharmacy, or 
unstable financial status are all examples of perceived barriers an individual may have. Like 
opioid addiction, HIV, AIDS, and related conditions carry stigmas that potentially prevent the 
seeking of medical assistance. A 2018 study applied the concepts of the Health Belief Model and 
demonstrated that the advantages of taking PrEP (Pre-exposure Prophylaxis) were frequently 
overpowered by the objective and perceived barriers of participants—preventing their use of the 
medication (Felsher, 2018). This finding suggests an important influence for perceived barriers 
over health behaviors that may be associated with a controversial group or idea.  
Self-Efficacy 
 The self-efficacy dimension addresses an individual’s confidence in their abilities to 
successfully perform a health behavior. In terms of this study, self-efficacy includes confidence 
in the ability to use or access naloxone in addition to general first aid and opioid knowledge.  
Applying the HBM to “External” Behaviors 
An important question to ask about analyzing the HBM in this context is whether or not it 
is applicable to a behavior outside of personal consequence. Naloxone ownership has the 
potential to be more beneficial for others than the individuals who are purchasing the drug 
themselves. The HBM has been empirically applied to behaviors that concern the health of 
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others, not just the self. A 2014 randomized controlled trial studied the impact of an HBM-
guided educational program upon safety and injury knowledge, HBM factors, and applied 
behaviors in mothers of young children. In this study, the mother’s development was centered 
around their child, and not them personally. Despite this deviation from traditional HBM studies, 
there were statistically significant increases in knowledge, perception, and integration into daily 
life (Cheraghi, Poorolajal, Hazavehi, & Rezapur-Shahkolai, 2014).  
Some may speculate that although the mothers in the experiment are taking health-related 
action to benefit others, they may have different motivations due to their close relationship with 
their children. However, other HBM studies have been performed that take this same concept 
and apply it on a broader, less intimate scale. In a 2019 study, Lynch and Jackson examined the 
influence of the Health Belief Model in the context of local gun control policies. Like naloxone 
education, this study is in the interest of public health and safety. Researchers found that 
perceived risk to loved ones influenced the immediate, situational health behaviors. The study 
also revealed that community attitudes toward the policy was more likely to impact any long 
term patterns of health behaviors regarding gun control. Thus, community values and helping 
behaviors are highly indicative of the ultimate executed health behavior. 
This concept is problematic due to the varying levels of prosocial behavior among 
individuals. This research must account for the fact that some people may acquire naloxone due 
to prosocial motivations, a factor not included in the HBM. This can be remedied by controlling 
for the influence of prosocial behavior in the assessment. By testing for prosocial behavior, we 
will be able to detect if this attribute is an important aspect of the individual variables that 
influence all aspects of the model.  
The Current Study 
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The objective of the current study is to increase the likelihood of obtaining anti-opioid 
drugs like Narcan for preventative use. This correlational study is designed to determine the 
strength and importance of various psychosocial mechanisms that influence the acquisition of 
anti-opioid drugs. The reported salience of these components can assist in the development of 
future educational interventions to increase knowledge of naloxone and eventually decrease the 
amount of opioid-related deaths.  
Hypothesis 
 My current hypotheses are based on the aforementioned findings. As a result, it is 
predicted that those who score highest for the health belief model factors will have higher intent 
scores. This assumption is based on the increased compliance with health behaviors when factors 
of the Health Belief Model are salient. Second, it is hypothesized that those who are more 
educated about naloxone will a) score higher in HBM factors, and b) higher in intent to fulfill the 
health behavior [acquiring the drug]. This hypothesis is rooted in the presumption that those with 
more relevant education and awareness have an additional motivating factor to acquire naloxone. 
Finally, the study predicts that those who score highly in prosocial behavior will a) score higher 
in HBM factors, and b) higher in intent to fulfill the health behavior. As it is the nature of 
prosocial behavior to assist others, prosocial behavior should increase perceived benefits to 
action for the individual. Consequently, this should result in increased HBM measures overall 
and an increased likelihood to acquire naloxone.  
Method 
Participants 
In order to eventually apply this research for use in the real world, the decision was made 
to select from the population most commonly affected by opioid overdose. According to a 2017 
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meta-analysis conducted by the CDC, American individuals between the ages of 25 to 54 
experienced the most dramatic increase in opioid overdose death (CDC, 2017). Because this 
group most frequently suffers from the adverse effects of opioids, it was deduced that increased 
naloxone possession in the same group would be beneficial. Due to this age group, only 
surveying fellow college students would not be conducive to accurate results. Therefore, it was 
decided to target an older group of individuals to sample from and adjusted my distribution 
accordingly.  
Exclusionary factors 
For the sake of focusing this study on the knowledge of the general public, health 
providers and first responders will be excluded from the study. The chance of prior exposure to 
naloxone education could skew the results if their data were included in the analysis.  
Materials  
Measures 
There is currently an absence of research that has observed naloxone use through the 
application of the HBM, so a new researcher-generated measure was used in this study. 
However, there is an abundance of research applying the HBM to other behaviors, so the 
questionnaire was modeled after empirically tested and validated measures.  
The present questionnaire consisted of a short demographic survey, a pre-questionnaire 
with 5 items, a main section with 31 items, and a final post-questionnaire stage. The pre-
questionnaire is designed to measure prior knowledge and experience with naloxone. Although 
not directly related to the HBM, this exposure measure can indicate our sample’s relationship to 
other empirical data, thus indicating whether or not we had a representative sample.  
After the first section is completed, participants are presented with a short informational 
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paragraph defining some medical terms and products that may appear in the next section. This 
allows for more wholesome and accurate responses regardless of the possession of prior 
knowledge about Narcan. The next section is the HBM questionnaire consisting of 6 parts: 5 
items for risk susceptibility, 5 items for risk severity, 5 items for benefits to action, 5 items for 
barriers to action, 5 items for self-efficacy, and 6 items for prosocial behavior. Items to measure 
each of the HBM factors were researcher-generated, but guided by multiple well-established 
HBM studies (See Becker, et al., 1974; Champion, 1999; Jones, Jensen, Scherr, Brown, Christy, 
& Weaver, 2015). An HBM composite score was generated by combining all scores of the 5 
individual variable scores for the model. Items 9, 21, and 27 (See Appendix A) were adapted 
from the Generalized Self-Efficacy Scale (Schwarzer & Jerusalem, 1995). The pro-social 
behavior section was adapted from the Helping Attitudes Scale (HAS) (Nickell, G., 1998).  
In the post-questionnaire, four questions were asked to estimate each participant's intent 
to acquire the drug, learn more about it, and spread the information. A combination of these four 
questions made up an “intent” composite score. Intent is essential to this research because it is a 
reliable predictor of behavior (Sheeran, 2002). A copy of the complete questionnaire is included 
in the appendices. 
Procedure 
A recruitment message (Appendix B) and a link to the USD Qualtrics survey was posted 
on Facebook. A short summary of the purpose of the study was included as part of this message. 
The message contained a statement that stated that the survey was voluntary and available to 
those 18 years or older.  
Clicking on the survey took participants to the first page of the Qualtrics survey. In order 
to move into the main part of the questionnaire, participants were required to read and agree to 
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the departmental informed consent document. If the participant agreed, they were taken to the 
first section of the questionnaire.  
At the end of the study, participants were thanked for their time and provided with links 
to helpful information if they wanted to learn more about naloxone or the opioid crisis in the US. 
The duration of the survey was roughly 10 minutes.  
Results 
Preliminary Analyses 
The current research consisted of a sample of 85 participants, two of which were 
excluded from the final study due to their medically-related occupations. The majority of the 
participants were female (80%), while male participants only made up 20% of the sample.  The 
racial makeup of the sample included 87% White participants, 1% American Indian or Alaska 
Native participants, 6% Asian participants, 2% Native Hawaiian or Pacific Islander participants, 
and 4% designated ‘Other’ participants.  
A vital part of this research involves looking into the participants’ familiarity with 
naloxone before taking the survey. Only 2% of participants claimed to be extremely familiar 
with the drug prior to participation. In contrast, 49% of participants indicated that they were not 
at all familiar with the drug. This percentile is slightly higher than the 41% in IBM Watson’s 
study and 35% in Kirane’s study that did not know what naloxone was. However, the lower 
percentage in Kirane’s study could be due to the sampled population which resided in an area of 
high opioid use (2016).  A complete representation of familiarity with naloxone is shown in 
Figure 2. Of those who indicated a minimum of slight familiarity with naloxone, 2% learned 
about it from personal experience, 7% from a medical professional, 7% through work, 5% 
through school or an educational program, 31% through media exposure, 2% from a friend, and 
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8% from other sources. In terms of exposure to the drug, 2% of the sample has been in 
possession of naloxone at some point in the past, while 96% have never owned it. All 
participants in the sample answered that they have never had to administer naloxone to someone 
else. Only 1% of the sample had naloxone administered to them in the past.  
Figure 2 
Familiarity Rankings for Naloxone 
 
Age Groups 
To check for significant differences between age groups, due to the reported age group 
differences from IBM Watson’s 2018 study and Kirane’s 2016 study, participants were split into 
6 age categories and compared through a one-way ANOVA. Participants ranging from 18 to 65+ 
years old acted as participants in the current study. The majority of participants fell between 45-
54 years old (63%). A series of one-way ANOVAs revealed no significant differences between 
the age group in all measured variables apart from prosocial behavior, F(5,70) = 7.403, p = .000. 
Post hoc comparisons using the Tukey HSD test revealed that the mean prosocial behavior score 
for the 18-24 age group (M = 17.22, SD = 4.09) score was significantly higher than both the 45-
54 (M = 11.92, SD = 3.09) and 55-64 age groups (M = 10.10, SD = 2.51). These tests also 
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indicated that the mean prosocial behavior score of the 25-34 age group (M = 18.50, SD = 6.61) 
was similarly higher than the means of the 45-54 and 55-64 age groups.  
Education 
Training and educational exposure have also been linked to heightened awareness and 
motivations to handle opioid overdoses (Behar, Santos, Wheeler, Rowe, & Coffin 2015). To see 
if these educational differences had influence over the studied variables, a one-way ANOVA was 
conducted to compare each educational group. The highest level of education for the participants 
ranged from High School Graduate to Doctorate Degrees. Participants with four year degrees and 
professional degrees made up 41% and 36% of the sample, respectively. A one-way ANOVA 
indicated a significant difference in risk severity between education groups, F(6,67) = 3.522, p = 
.004. The mean score for those with a Professional degree (M = 10.30, SD = 3.05)  was 
significantly lower than those with a 2 year degree (M = 16.33, SD = 3.21) or a 4 year degree (M 
= 12.00, SD = 3.10). To determine any differences in perceived barriers in educational groups, a 
one way ANOVA was run, F(6,69) = 2.941, p = .013. A subsequent Tukey HSD test revealed 
that those with a doctorate (M = 26.33, SD = 5.03) scored significantly higher than all other 
educational groups for perceived barriers. There were no other significant differences between 
educational groups for any other of the measured variables.  
Composite Scores 
Average scores for each individual variable were calculated. Benefits to Action, Barriers 
to Action, Self-Efficacy, Risk Susceptibility, and Risk Severity were all scored on a scale 
ranging from 5 to 35. Scores closer to 5 indicated higher values of the studied variables, while 
scores closer to 35 indicated a weak motivation. To simplify, scores less than 15 indicated high 
affinity for the variable, scores between 15 and 25 were medium, and values above 25 were 
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considered low. On average, the studied sample ranked high in perceived benefits and risk 
severity, medium for barriers to action and self-efficacy, and low in risk susceptibility. The 
overall HBM composite score was based on a combination of the five previously mentioned 
variables and given a score ranging from 30 to 175.  The overall HBM composite scores 
collected had an average of 96 (M = 96.16, SD = 13.04). This score would fall in the moderate 
strength for all combined HBM factors. Prosocial behavior was calculated from a sum of 6 
questions on a scale of 6 to 42. On average, the participants scored as high in prosocial behavior. 
Lastly, the intent composite summed the results from the items described in the post-
questionnaire. This score was measured on a scale from 4 to 28. The average participant score 
indicated high levels of intent. Internal consistency was calculated using average inter-item 
correlations for each variable instead of Cronbach’s alpha due to the small number of factors 
(Table 1).  
Table 1 
 
Average Scores for HBM Factors, Prosocial Behavior, and Intent 
 
 M SD Average Inter-Item Correlation 
Benefits to Action 14.45 4.39 .2883* 
Barriers to Action 17.33 4.61 .1429 
Self-Efficacy 20.72 4.51 .2086* 
Risk Susceptibility 26.09 3.98 .2105* 
Risk Severity 11.88 3.57 .0925 
Prosocial Behavior 12.68 4.01 .2379* 
Intent 14.67 4.24 .4333* 
Note. *Items fall in ideal range between .15 and .50. 
 
Main Analyses 
The relationships between factors of the HBM, Prosocial Behavior, Familiarity, and 
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Intent to complete the health behavior were evaluated using Pearson correlations to determine 
the strength and significance of their associations.  
Benefits to Action 
Multiple results represented in Table 2 demonstrate important relationships for benefits to 
action. According to the hypotheses, perceived benefits were predicted to have positive 
significant relationships with familiarity, prosocial behavior, and intent. As shown in the table, 
perceived benefits to action have a weak, positive correlation with familiarity with naloxone. 
Understandably, perceived benefits demonstrated a similar relationship in the opposite direction. 
Higher benefits to action scores were also weakly associated with higher perceptions of risk 
susceptibility. Additionally, measures of prosocial behavior were weakly correlated with 
perceived benefits to action. Intent as measured by the survey also held a weak, but positive 
correlation with benefits to action. Benefits to Action scores were not significantly correlated 
with self-efficacy or risk severity.  
Barriers to Action 
 The completed Pearson correlations also indicated significant relationships for the 
barriers to action variable (Table 2). This study hypothesized a significant inverse relationship 
between perceived barriers and the measured variables. Perceived barriers had a moderately 
strong negative correlation with naloxone familiarity. As mentioned previously, barriers to action 
and benefits to action were weakly negatively correlated with one another. Furthermore, self-
efficacy also had a weak, but significant negative relationship with perceived barriers. Barriers to 
action were additionally weakly negatively correlated with beliefs of risk susceptibility. Higher 
barriers to action scores were also weakly associated with lower estimations of prosocial 
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behavior and intent to acquire naloxone. There were no significant relationships between 
perceived barriers and risk severity.  
Table 2                                                                                                 
P Values for Two-Tailed Pearson Correlations of HBM Factors and Related Variables 
Variable 1 2 3 4 5 6 7 8 
1. Familiarity  - .375** -.537** .495** .254* .114 .149 .226* 
2. Benefits to 
Action  
.375** - -.415** .181 .252* .182 .388** .350** 
3. Barriers to 
Action  
-.537** -.415** - -.323** -.340** -.159 -.365** -.289* 
4. Self-Efficacy  .495** .181 -.323** - .235* .045 .234* .315** 
5. Risk 
Susceptibility  
.254* .252* -.340** .235* - -.045 .036 .203 
6. Risk Severity .114 .182 -.159 .045 -.045 - .479** .103 
7. Prosocial 
Behavior 
.149 .388** -.365** .234* .036 .479** - .209 
8. Intent .226* .350** -.289* .315** .203 .103 .209 - 
Note. **. Correlation is significant at the 0.01 level (two-tailed).  
*. Correlation is significant at the 0.05 level (two-tailed). 
Self-Efficacy 
Based on the assumptions of the Health Belief Model, higher efficacy scores were 
predicted to coincide with higher intent to acquire naloxone. Similar to the two previous 
variables, the Pearson correlations indicated a moderate positive correlation between self-
efficacy and familiarity with naloxone. Self-efficacy also demonstrated a weakly negative 
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relationship with perceived barriers to action. Self-efficacy also had a significant and weakly 
positive correlation with risk susceptibility. A Pearson correlation also demonstrated a weak 
positive correlation with prosocial behavior. Tests additionally identified a significant positive 
correlation between self-efficacy and intent Self-efficacy did not demonstrate any significant 
correlations with benefits to action or risk severity (Table 2).   
Risk Susceptibility 
It was hypothesized that those who believe that they are more likely to be affected by an 
opioid overdose would be motivated and thus possess higher intent to purchase a dose of 
naloxone. A Pearson correlation found a weak positive correlation between risk susceptibility 
and familiarity with naloxone. Additionally, correlations revealed a weakly positive relationship 
between risk susceptibility and benefits to action. A Pearson correlation also demonstrated a 
weak negative correlation between risk susceptibility and perceived barriers to action. Tests also 
indicated a significant weak positive correlation between risk susceptibility and self-efficacy. 
Risk susceptibility was not significantly correlated with risk severity, prosocial behavior, or 
intent (Table 2).  
Risk Severity 
Following the ideas outlined by the HBM, belief in severe consequences if naloxone was 
not used would be hypothesized to motivate compliance with the health behavior. A Pearson 
correlation demonstrated a significant moderate positive correlation between risk severity and 
prosocial behavior. Risk severity did not demonstrate significant correlations with familiarity, 
perceived benefits, perceived barriers, risk susceptibility, self-efficacy, or intent (Table 2). 
HBM Composite Scores 
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HBM composite scores were generated by combining the scores of perceived benefits, 
perceived barriers, self-efficacy, risk severity, and risk susceptibility. Perceived barriers were 
reverse coded because they are a limiting factor, while the other variables encourage a health 
behavior. A Pearson correlation found a significant positive correlation between the HBM 
Composite Score and intent to complete the studied health behavior (Table 3). An additional 
Pearson correlation found a significant positive correlation between the HBM Composite Score 
and familiarity with naloxone (Table 3). The HBM Composite was also found to have a strong 
positive correlation with prosocial behavior (Table 3).  
Other Correlations 
A Pearson correlation found a significant positive correlation between familiarity and 
intent scores. Prosocial behavior was found to not have a significant correlation with either intent 
(p = .072) or familiarity (p = .200).  
Table 3     
P Values for Two-Tailed Pearson Correlations of Composite Scores 
Variable HBM Composite PB Composite Intent Familiarity 
HBM Composite 1 .507** .467** .594** 
Prosocial Behavior .507** 1 .209 .149 
Intent .467** .209 1 .226* 
Familiarity .594** .149 .226* 1 
Note. **. Correlation is significant at the 0.01 level (two-tailed). 
*. Correlation is significant at the 0.05 level (two-tailed).  
Discussion 
 The results of this study revealed several important relationships between the Health 
Belief Model and naloxone possession. Additional data helped to expand a growing body of 
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research on the public’s understanding and attitudes regarding anti-opioid drugs. Half of the 
sample was indicated little to no awareness of naloxone and its uses. This value speaks to the 
significance of unawareness of anti-opioids in the American public. Furthermore, of those who 
were familiar with naloxone, the majority learned about the drug through exposure to television, 
movies, and books, while a very small percentage gained their knowledge from a medical 
professional. As this knowledge is not being acquired through reputable channels, there is the 
risk of stigma and sensationalization of overdose prevention and anti-opioid drugs. The lack of 
individuals who learned about naloxone from a medical professional demonstrates a shortage of 
educational opportunities and interventions that should already be occurring in the healthcare 
field.  
The strongest relationships between the individual factors of the HBM, prosocial 
behavior, familiarity, and intent were between familiarity and barriers to action, familiarity and 
self-efficacy, benefits to action and barriers to action, and risk severity and prosocial behavior. 
Although each of the individual HBM factors demonstrated important relationships, perceived 
barriers had the most salient relationships with intent, prosocial behavior, and incoming 
knowledge. These findings are consistent with those of Felsher’s (2018) study on patient 
reluctance of starting on PrEP. It is logical that this relationship would exist for a controversial 
issue like opioid use which may have more barriers preventing action than more normalized 
health behaviors. Future attempts to increase naloxone ownership should pay particular attention 
to minimizing perceived barriers to accessing the drug. Some potential ways of executing this 
would be through educational programs, financial support, or through social initiatives that seek 
to minimize the stigma associated with drug use. 
The HBM Composite score was significantly correlated in a moderate, positive direction 
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for prosocial behavior, familiarity with naloxone, and intent to complete the health behavior. 
This result is important because it supports Hypothesis 1: HBM motivators will be associated 
with higher intent. Hypothesis 2 was partially supported. Familiarity with naloxone had a 
moderately strong positive relationship with overall HBM score. However, the results only 
supported a weak positive relationship between familiarity and intent. Finally, Hypothesis 3 was 
partially supported. Prosocial behavior displayed a moderately strong positive relationship with 
total HBM scores but held no significant relationship with intent. Of the four variables 
compared, the HBM composite held the most and strongest correlations with the other variables. 
These results support the importance of each of the motivators outlined by the HBM upon 
multiple factors that encourage the acquisition of naloxone.  
Potential Limitations 
 There were some notable limitations to this research. Primarily, the sample utilized for 
collecting data was a convenience sample. The participants were mainly white females between 
the age of 45 and 54. Additionally, many of the participants were local, California residents. 
California is a state with good Samaritan overdose protection laws, which may influence 
participants’ motivations and behaviors during an overdose situation . As a result of this 
arrangement, the data may not apply to the larger United States population.  
 There was also an element of control that was sacrificed by conducting this survey 
remotely. The Qualtrics survey was open for the period of one week, but participants could take 
it when and wherever they wanted. Therefore, a controlled environment could not be confirmed 
for all participants. 
This research was also conducted during the Corona Virus pandemic. The heightened 
stress and focus on a different medical issue may have swayed participant responses. As this 
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study was also the first of its kind, further replications and adjustments to procedure and surveys 
are required to fully explore the complicated nature of this issue. 
Broader Implications 
This exploratory study could potentially help to shape further research on anti-opioid 
medications, develop programs that operate on these findings, or even help to guide future 
legislation on the availability and public knowledge of Narcan. By determining which 
component(s) of the Health Belief Model hold more weight in the topic of Narcan education, we 
can model future efforts and interventions with these dimensions in mind. A more thorough 
understanding of the American public’s motivations and limitations to education about Narcan 
can help to mold a more effective approach to address this issue. The ultimate goal of all of this 
research and increased education is to counteract the amount of deaths caused by opioid 
overdoses in the United States. A more educated and capable population would be more prepared 
to aid in the situation of an overdose—saving lives in the process. Of course, ideally, the use of 
narcotic drugs would be the favorable behavior to correct, but drug addiction is a complex and 
multifaceted phenomenon; more time and research are needed to address this deeply-rooted 
issue. In the meantime, however, prevention and education are the best tools we have to fight the 
opioid epidemic from a psychological perspective.  
The positive impact of this research is not only confined to anti-opioid drugs like Narcan. 
Hopefully, the motivational aspects discerned from the data can assist applied psychologists in 
the adaptation of programs that help prevent or treat other types of overdoses (or similar 
behavior). Reaching beyond drug addiction and medical intervention, the factors influencing 
individual’s health behavior can ideally provide clues and guidance for the involvement of the 
public in other controversial health issues. Furthermore, this study can hopefully contribute to 
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the growing body of research of the HBM and the operation of its dimensions in various areas of 
medicine. 
In order to ensure the validity and generalizability of these findings, further research is 
required. This study did not address the potential benefits of combined dimensions of the HBM 
in the encouragement of Narcan knowledge and possession. Further correlational studies and 
experiments must be conducted in order to detect any interactions between the dimensions of the 
HBM. Furthermore, a longitudinal aspect could be added in order to investigate the endurance of 
intended health behaviors. A copy of the post-test questionnaire could be administered to the 
participants again six months or one year after initial testing. This will allow us to investigate 
memory and time as potential barriers to Narcan education.  
Ultimately, it is my hope that doctors, pharmaceutical companies, and other health 
professionals use the findings of this research to tailor their discussion of Narcan with their 
patients. Their involvement will create a more direct line of communication with patients that 
has been shown to be associated with an increase in executing a desired health behavior.  
Conclusion 
Despite the opioid epidemic, many Americans are unaware of how to act in the event of 
an overdose. Naloxone is a widely available drug that can reverse these effects if delivered in a 
timely manner. Although naloxone does not require a prescription or specialized medical 
training, few outside of the medical field own doses of this life-saving medication. An 
exploratory questionnaire was distributed to discern the relationship of various motivational 
factors in the acquisition of anti-opioid drugs. Results from this survey demonstrate a prominent 
lack of knowledge about naloxone. Correlational data supports a positive relationship between 
the sum of Health Belief Model factors and intent to purchase naloxone. Data also revealed a 
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significant and positive relationship between the HBM factors and prosocial behavior measures. 
Positive correlations were also demonstrated between naloxone familiarity and HBM factors. 
These outcomes support the influential nature of the Health Belief Model in determining actions 
regarding anti-opioid drugs. Prosocial behavior and previous knowledge also demonstrated 
important relationships with intent. Moving forward, the Health Belief Model, paired with extra 
attention to education and encouraging prosocial acts, may be used to formulate a new public 
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Applications: Increasing Naloxone Awareness 
A Literature Review of Public Health Initiatives & The War on Drugs in the Context of the 
Health Belief Model (HBM) 
Introduction 
With the information from the previous study, we can begin to conceptualize a public 
health initiative based on the components of the Health Belief Model. To do this, it is vital to 
have a basic understanding of the historical use and success of public health initiatives in the 
United States. Previous and current anti-drug movements have relied heavily on scare tactics and 
seek to achieve complete eradication of drugs. However, through the exploration of the 
effectiveness of these campaigns in concert with the previous research on the Health Belief 
Model, it is more feasible to begin promoting a system centered around the HBM to reasonably 
deal with the country’s current issues.  
Historical Background 
 There is undoubtedly controversy and stigma surrounding drugs and drug use in the 
United States. This climate inevitably impacts any efforts of the American public to promote 
naloxone ownership and limit the amount of annual deaths by opioid overdose. While there have 
been various levels of involvement in the control of drugs since the establishment of the United 
States, the more draconian policies did not begin until Ronald Reagan’s presidency. This is what 
is popularly considered to be the start of the American “War on Drugs”. The heightened 
regulation of substances and related punishments were enforced by a combination of legislation, 
social movements, and the establishment of governmental departments, such as the Drug 
Enforcement Administration (DEA) (War on Drugs).  
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 As mentioned previously, American government and society are theoretically aiming for 
complete abstinence from drug use. This is one of the crucial challenges to promoting the 
ownership of anti-opioid drugs. Other harm reduction, or what Drucker and Clear refer to as 
“drug maintenance”, initiatives have experienced similar pushback (1999). Due to this attitude of 
complete opposition instead of one of assistance and maintenance, the current response to the 
opioid crisis in the United States is lacking in its success. In order to re-evaluate and correct the 
approach to this issue through the promotion of naloxone ownership, we must educate ourselves 
about the successes and failures of past drug campaigns. This can provide insight for the creation 
of practical and accessible solutions that utilize previously established systems and information 
to address the opioid crisis from a different perspective. Instead of expecting the American 
public to say “just say no”, we should prepare them to say “we are ready and able to help”.  
Public Health Initiatives  
When analyzing the success of past public health initiatives, it is important to 
acknowledge the role of public service announcements (PSAs) and similar campaign 
commercials. These ads act as the prominent feature for many past public health initiatives in the 
United States (Palmgreen & Donohew, 2003). Due to the large audience that these campaigns 
reach, it is vital to have a thorough understanding of how they operate to influence health 
behaviors. The popularity of these PSAs is evidenced by the collective memory of famous anti-
drug campaigns, such as Partnership for a Drug-Free America’s This is Your Brain on Drugs ads, 
the CDC’s Tips From a Former Smoker series, and Michael Jordan’s “Stop it, get some help” 
PSA, to name a few. Despite their prevalence in American society, these ads have failed to 
accomplish their purpose.  
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The American government has acknowledged the ineffectiveness of its previous 
campaigns against drugs. In a 2006 report from the Government Accountability Office, 
researchers examined the success of the National Youth Anti-Drug Media Campaign. This $1.2 
billion dollar endeavor proved to be ineffective in discouraging drug use in American youth. The 
report even addresses the possibility of a “boomerang effect”, meaning that the campaign may 
have resulted in higher levels of youth involvement with drugs. In 2012, Magura and associates 
performed a meta-analysis of the GAO report and program itself. This research concluded that 
the National Youth Anti-Drug Media Campaign failed to accomplish its goals, but hesitated to 
agree with the presence of a boomerang effect. This begs the question: what exactly has resulted 
in such failures for these health initiatives?  Many of these anti-drug campaign ads have a 
similarity which is most likely their downfall—an overzealous use of fear.  
Fear Appeals 
 The use of scare-tactics in anti-drug movements is problematic due to the empirical 
evidence that cites its ineffectiveness. In Keller’s 1999 experimental studies, it was demonstrated 
that scare tactics were only successful for individuals who already practiced whatever health 
behavior was being promoted. Alternatively, the research showed that those who did not already 
practice this behavior had a negative correlation between level of fear and persuasion to 
complete the behavior. Furthermore, a 2015 meta-analysis of the effectiveness of fear appeals 
references the Health Belief Model and other psychological theories when claiming support for a 
more diversified approach to persuasion. At a bare minimum, researchers suggest that appeals to 
fear should operate in tandem with efficacy-reinforcement in order to be effective (Tannenbaum, 
Hepler, Zimmerman, Saul, Jacobs, Wilson, & Albarracín, 2015). However, despite the 
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overwhelming amount of evidence demonstrating the failures of scare tactics, they are still used 
in many drug prevention campaigns; including those for naloxone.  
Current Media Approaches to Naloxone Promotion 
 When searching the phrase “naloxone PSA” on YouTube, a total of 51 videos populate—
a small number considering YouTube’s illustrious library of content . Searching the phrase 
“Narcan PSA” produces significantly more results, but both searches yield the same top five 
videos. We can use these clips to gain insight to the current approach to naloxone public service 
announcements and their effectiveness. To demonstrate this, short descriptions of each video will 
be provided along with an analysis of their use of scare tactics as well as utilization of the HBM 
factors to encourage naloxone ownership. 
Video 1: Nasal Narcan PSA, Stoughton Police 
 The most popular video, with 74,000 views, opens with ominous music and text overlaid 
on a black screen with the prior year’s drug-related death toll in Massachusetts. This is a telling 
indicator for the remaining content of the video. Examples of scare tactics used in the video 
include a hysterically crying mother, loud police sirens, and images of graveyards, drugs, and 
needles. The PSA makes an appeal to risk susceptibility by demonstrating a mother dealing with 
the aftermath of her son’s overdose. By using a familiar relationship between a parent and child, 
the video creates a more generalizable message. The video primarily focuses on portraying risk 
severity associated with opioid overdose. The subject of the video is shown to be unconscious 
and unresponsive with blue lips and bloodshot eyes. The previously mentioned fear imagery also 
operates as a reminder of risk severity. Benefits to action are not as obvious within the PSA. The 
primary benefit to the mother calling 911 is the arrival of emergency services, while the benefit 
to their arrival is the resuscitation of the patient. Barriers to action are also not highly apparent in 
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the video. Self-efficacy in regards to intervening during an overdose is not reinforced because 
the only individuals interacting with the overdose-reversal drug are the first responders. In 
summary, this PSA relies mostly on scare tactics stereotypically associated with campaigns 
against drugs. While risk severity is communicated through the video, there is no demonstration 
of how to use naloxone as a bystanding citizen. The video does provide a website and phone 
number for obtaining Narcan, but this is only at the end of the four minute PSA.   
Video 2: Good Samaritan PSA (Heroin Overdose/Narcan), Drug Free Manatee 
The second most-viewed naloxone PSA takes a slightly different approach to the concept 
of opioid overdoses. While it portrayed the consequences of an overdose in a similar manner to 
the first video, this PSA primarily focuses on the Good Samaritan Laws in Florida. Despite its 
differing orientation, scare tactics are still employed frequently in the 30 second ad. Images of a 
used needle, yelling voices, and statistics about overdose deaths are utilized to make the audience 
aware of the negative consequences of drug use. While it is not clear what the relationship is 
between the man who alerted authorities and the woman who overdosed, it can be inferred that 
they are friends, or at least acquaintances. This familiar social connection may prompt the 
audience to think about friends that may be susceptible to an opioid overdose. Like the first PSA, 
this video emphasizes risk severity. The unconscious woman with blue lips, an audibly racing 
heartbeat, medical equipment, and flashing lights of emergency vehicles reinforce the danger of 
the situation. Barriers to action are demonstrated in this video via the argument the friends have 
over whether or not to call the police. Concerns about being cited for drug possession can be an 
influential barrier to taking action during an overdose. This ad takes a more direct approach to 
benefits to action by having the police officer tell the man that called 911 that this action saved 
the woman’s life. Self-efficacy is promoted by showing the man playing an active role in the 
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situation. However, there is no emphasis on self-efficacy specifically related to naloxone, 
because there is no on or off-camera references to the use of an overdose-reversal drug. Overall, 
this PSA is helpful in educating Floridian citizens about the legal protections they are afforded 
when intervening with an overdose. While this is a step in the right direction, the PSA fails to 
recognize the ability for citizens to administer naloxone; a health behavior that could potentially 
save a life while emergency services are transported to the scene.  
Video 3: PSA: Naloxone : 30, Maryland Department of Health and Mental Hygiene  
The third video focuses on a stereotypical drug user: a gloomy teen with smudged 
makeup wearing all dark clothes. While there are fewer scare tactics present in the PSA, the 
parent’s whispered discussion and the daughter’s collapse to the ground call attention to the 
danger associated with opioids. Similar to the first video, this PSA utilizes the parent-child 
relationship to increase perception of risk susceptibility. Furthermore, the voice-over indicates 
that prescription opioids can also cause addiction; while some individuals may not feel 
susceptible to recreational drugs, taking prescribed medication is a common experience that 
many can relate to. Risk severity is portrayed through the daughter’s loss of consciousness to 
signify the overdose. This PSA works to actively reduce barriers to action by demonstrating that 
it is possible to have overdose-reversal drugs in the household and by working to dismiss the 
harmful stigma surrounding drug use. The daughter’s return to consciousness after her mother 
administers naloxone is a clear marker of benefits to action. Self-efficacy is a prominently 
featured issue in this PSA. The parents’ quick responses, knowledge and ownership of the drug, 
and successful administration all operate as a successful model for the audience. This PSA is 
successful in appealing to all aspects of the Health Belief Model. It could be further improved by 
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demonstrating how to assemble and administer doses of naloxone and using costumes or actors 
that do not fit the stereotypical category of “drug user”.   
Video 4: Narcan Administration PSA, Whitestown Fire Department 
The fourth video takes an instructional approach to naloxone and drug overdoses. The 
local chief of the fire department speaks about naloxone, opioid addiction, and overdose during 
the PSA. Scare tactics are limited to mentions of possible death as a result of opioid overdose as 
well as the imagery of an unconscious victim with drugs, a needle, a home-made tourniquet, and 
vomit. Like the Good Samaritan PSA, risk susceptibility is communicated through the common 
relationship of friendship. The friends that find the overdose victim could easily be anyone. One 
barrier mentioned in the PSA is naloxone’s inability to “cure” addiction. As the drug is not a 
complete solution, but simply an aid in the direction of rehabilitation, individuals may find 
themselves more reluctant to acquire it. Additionally, the ER doctor speaking in the video states 
that naloxone and other anti-opioids will not counteract the effects of other types of drugs. The 
PSA does manage to counteract some of the negative associations of drug use by referring to 
addiction as a disease, not an intentional or destructive choice. In terms of benefits to action, the 
Fire Chief repeatedly references the usefulness and effectiveness of naloxone. Arguably, self-
efficacy is the main focus of this PSA. The reenactment demonstrates the friends following first-
aid protocol, calling 911, administering a dose of Narcan, and moving the man to a recovery 
position. The PSA also includes discussion of the three types of naloxone kits that can be 
purchased at a pharmacy—including assembly and administration instructions. This video is a 
prime example of what more anti-drug PSAs should look like: information- and efficacy-focused 
without unnecessary scare tactics. That being said, the video only has 1,360 views (as of 
NALOXONE EDUCATION & THE HEALTH BELIEF MODEL                                             34 
November 9, 2020). Despite the positive attributes of this PSA, it is not reaching a large enough 
audience to have a thorough impact on American society.  
Video 5: PSA: Naloxone : 15, Maryland Department of Health and Mental Hygiene 
This public service announcement is an abridged version of Video 3. All points 
mentioned for the full version still apply to this video (see above). 
Naloxone PSAs: Debrief 
As demonstrated above, many of the currently available PSAs for naloxone are overly 
reliant on scare tactics. The ads demonstrate the usefulness of the drug, but this can easily be lost 
within the overt death and fear-related messages. The PSAs that were successful in most fronts, 
such as the Whitestown Fire Department PSA, were lacking in their outreach capabilities. Future 
development of naloxone PSAs should use appeals to the HBM as opposed to falling back onto 
the traditional methods used by anti-drug campaigns.  
Shifting to a HBM-Based Approach 
Looking back to our Health Belief Model, we can see that a fear-based approach only 
really addresses the perceived severity element. This is problematic because the questionnaire 
data as well as a growing body of research indicates that all five factors are relevant in the 
determination of a health behavior. As seen for the issue of anti-opioid knowledge and 
ownership, barriers to action are especially significant. Due to this significance, barriers to action 
should be given specific attention, but all of the other factors must be addressed as well. As 
further research is conducted, the proposed plan can be altered by putting emphasis on any of the 
five factors of the HBM based on a community’s needs and relevant trends.  
Perceived Susceptibility 
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In terms of increasing the American public’s perceived susceptibility to opioid overdose, 
there are a variety of possible approaches to take. One possible tactic would involve the 
increased awareness of “average” people who develop drug addictions. What many fail to 
recognize is that there are several types of opioid drugs that are legally prescribed by a medical 
professional. Therefore, it is entirely feasible that an addiction could develop over the course of 
recovery from a surgery or other common medical issue. What is essential about increasing 
perceived susceptibility is getting Americans away from the mindset that addiction only happens 
to a specific “other” group of people. It is a common issue that no one is automatically excluded 
from. Furthermore, the publication of rates of addiction, opioid use, opioid overdose, and opioid-
related fatalities could be utilized to promote ownership of naloxone by appealing to individuals 
who are more likely to be influenced by data and numbers.  
Perceived Severity 
To increase the perceived severity of opioid addiction, we can take a modified approach 
to current anti-drug campaigns. However, instead of using scare-tactics to threaten individuals 
into acquiring naloxone, these campaigns can appeal to severity through the use of a different 
approach. Kingsbury’s 2015 study on heavy drinking intentions explored the impact on behavior 
when individuals are presented with a health gain or loss or, alternatively, a social gain or loss. 
Researchers found that those presented with social loss or health gains drank the smallest amount 
of alcohol (Kingsbury, Gibbons, & Gerrard, 2015). We can apply this concept of appealing to 
social consequences and health benefits in future PSAs for naloxone. For example, ads could 
present the social consequences of not having naloxone on hand or by emphasizing the health-
related advantages or being prepared for an opioid overdose. This is a more empirically-
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supported method than relying on historically ineffective fear tactics to address naloxone 
ownership.  
Benefits to Action 
Increased understanding of benefits to action can be promoted through PSAs, medical 
interactions, and social discourse. This could involve sharing personal stories of gratitude and 
recovery to demonstrate how someone’s life was turned around after they were given a dose of 
naloxone. Additionally, figures demonstrating the number of lives saved by naloxone could 
provide concrete evidence of its success rate. PSAs could also present naloxone ownership as an 
opportunity to assist a friend, family member, or neighbor and bring peace of mind for the 
individual who owns it.   
Barriers to Action 
There are multiple dimensions that must be considered in order to reduce barriers to 
action in the United States. Four substantial barriers at the forefront of this issue are social 
stigma, pharmaceutical knowledge, legal barriers, and monetary barriers. Social stigma is a 
significant issue ingrained within the American societal cognition. It is difficult to address this 
issue in its entirety due to its overarching presence, but there are steps we can take to reframe the 
societal approach to drug overdose. PSAs should actively make an effort to not demonize drug 
users or paint them in any subhuman context. The lack of pharmaceutical and medical 
professionals that are well-versed in anti-opioids and overdose prevention also presents a major 
complication. As of 2016, Australia legalized the sale of naloxone from pharmacies without a 
prescription. Despite naloxone being theoretically available to anyone who asks for it, there were 
many complications that prevented this from being the case. In a survey of nearly 600 Australian 
pharmacies, the majority of reporting pharmacists expressed reluctance in their ability to provide 
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education about the drug and similarly did not feel capable of identifying customers who needed 
naloxone. Most alarmingly, only 41% of participating pharmacists expressed a willingness to 
provide naloxone over the counter (Nielsen, Menon, Larney, Farrell, & Degenhardt, 2016). This 
indicates that more than half of all pharmacies would turn someone away that asked for a legal 
drug. This creates barriers which are typically uncontrollable for the average citizen. As 
Australian regulations and social climate as addressed in the study are comparable to the United 
States, we can apply the same conclusions to our own society. Furthermore, states that lack 
legalized ownership of naloxone and Good Samaritan laws also act as barriers to action. Through 
increasing education about naloxone in all fields, hopefully state and federal governments will 
recognize the advantages to legalizing naloxone throughout the country. Lastly, monetary 
barriers may also limit individuals from obtaining the drug. Many organizations have made 
efforts to counteract this barrier by providing free or discounted overdose kits (which include 
naloxone) to drug-users, their friends, and families (National Harm Reduction Coalition). 
Continuing support of such programs will be essential to reducing barriers to action.  
Self-Efficacy 
Finally, self-efficacy must also be addressed in order to increase awareness of naloxone. 
PSAs and workshops instructing individuals where and how to access naloxone could serve to 
increase the American public’s confidence in being able to bring the drug into their household or 
place of work. Other programs and flyers could also be designed to demonstrate how to assemble 
and administer the drug during an emergency situation. Having these discussions and 
instructions integrated into traditional first aid training could also allow individuals to safely 
practice giving naloxone under the guidance of a trained professional.  
Conclusion 
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The United States’ historical relationship with drugs is one built upon fear and 
misunderstanding. This complicated connection eventually led to the creation of public health 
initiatives designed to decrease drug use that frequently utilized threats of extreme loss and 
danger. However, this method of dissuading the American public has not been effective and has 
left them overwhelmingly underprepared. The promotion of naloxone ownership to counteract 
some of the negative consequences of the opioid epidemic should follow a Health Belief Model 
framework in order to successfully appeal to and protect the American people. This approach 
will involve acknowledgment of the influence of perceived severity, perceived susceptibility, 
barriers to action, benefits to action, and self-efficacy. A shift to public health initiatives modeled 
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Age:  18-24   25-34   35-44   45-54   55-64   65+ 
Gender:  Female    Male    Other:_____________    Prefer not to say 
Career/Job Title:________________________________________________________ 
Race/Ethnicity: Asian/Pacific Islander    Black or African American  Hispanic or Latino     
Native American/American Indian   White/Caucasian   Other   Prefer not to say    
Highest Education Level:  Less than High School      High School Graduate   Some college             
2 year Degree   4 year Degree Doctorate   Other  
Health Insurance Status (as of today): Insured    Uninsured   Prefer not to say   
 
 
Part 1: Pre-Questionnaire 
 
How familiar are you with naloxone (aka Narcan)? 
❏ Extremely familiar 
❏ Very familiar 
❏ Moderately familiar 
❏ Slightly familiar 
❏ Not familiar at all 
 
Continue to the next question unless you answered “Not familiar at all”.  If you were not 
familiar at all, skip to Part 2 of the survey. 
 
Where did you learn about naloxone? (Select one or more answers below) 
❏ Personal experience 
❏ A medical professional 
❏ Through work 
❏ Through school/educational program 
❏ Through media exposure (Television, movies, books, songs, etc.) 
❏ A friend 
❏ Other:______________ 
 
Have you ever been in possession of naloxone? 
Yes       No  Maybe 
 
Have you ever administered naloxone to someone else? 
 Yes       No  Maybe 
 
Has anyone ever administered naloxone to you?  
 Yes       No  Maybe 
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Some helpful information for answering the next section!  
Naloxone/Narcan: “a drug administered by injection or as a nasal spray to reverse the effects of 
opioids especially in the emergency treatment of opioid overdose” 
 
Opioids: “a natural, semisynthetic, or synthetic substance that typically produces narcotic effects 
(such as sedation, pain relief, slowed breathing, and euphoria)” 




Part 2  
 










(1) (2) (3) (4) (5) (6) (7) 
 
 
1. When the public is educated about a health issue, they are more able to help address it.  
2. I know what to do if someone overdoses on opioids 
3. I believe drug use is a major inhibitor to good health. 
4. I know where to acquire naloxone 
5. When given the opportunity, I enjoy aiding others who are in need. 
6. My chances of a drug overdose are low.  
7. Giving aid to the poor is the right thing to do. 
8. Having access to an anti-opioid drug would let me help others in the event of an 
emergency.  
9. I can usually handle whatever comes my way.  
10. It is generally easy for opioid drugs to be managed and taken safely. 
11. If I buy naloxone, people will think that I take drugs.  
12. If the person in front of me in the check-out line at a store was a few cents short, I would 
pay the difference. 
13. Drug overdoses in my community are rare. 
14. If more people had naloxone, the negative effects of the opioid epidemic could be greatly 
reduced. 
15. I expect others to step in and help during an overdose before me. 
16.  A dose of naloxone will not be helpful for someone experiencing an overdose.  
17. It is not my responsibility to help opioid addicts 
18. I try to offer my help with any activities my community or school groups are carrying 
out. 
19. Someone in my neighborhood/community will likely overdose on opioids  
20. I believe naloxone will contribute to continued opioid addiction 
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21. I am confident that I could deal efficiently with an opioid overdose. 
22. The opioid crisis is over-exaggerated.  
23. I know how to obtain preventative doses of anti-opioid drugs  
24. I dislike giving directions to strangers who are lost.  
25. I can easily imagine a family member overdosing on opioids. 
26. I believe naloxone would help the person it is given to.  
27. Remaining calm in the event of witnessing a drug overdose will be challenging for me. 
(reverse code) 
28. A drug overdose significantly impacts a person’s life 
29. $45 is too much to pay for naloxone.  
30. Helping people does more harm than good because they come to rely on others and not 
themselves. (reverse code) 
31. I will likely overdose on opioids in my lifetime. 
 
(Part 3) End of survey 
 









(1) (2) (3) (4) (5) (6) (7) 
 







Unimportant Not at all 
Important 
(1) (2) (3) (4) (5) (6) (7) 
 









(1) (2) (3) (4) (5) (6) (7) 
 









(1) (2) (3) (4) (5) (6) (7) 
 
Here are some helpful weblinks if you wish to learn more!  
How to Get Naloxone without a prescription 
https://www.goodrx.com/blog/heres-how-to-get-naloxone-the-opioid-overdose-antidote-without-
a-prescription/ 
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Identifying an Overdose and Instructions on How to Administer Anti-Opioids 
https://drugfree.org/article/overdose-response-treatment/ 
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Appendix B 
Recruitment Message 
A Psychological Approach to Public Health Models 
My name is Sarah Tilford and I am working on my Honors Thesis in the Department of 
Psychological Sciences at the University of San Diego.  I am collaborating with my professor, Dr. 
Rebekah Wanic, on a study about anti-opioid drugs.  We are interested in learning more about 
what motivates members of the general public to purchase, learn about, and use these medications.   
The study involves a short questionnaire and should take roughly 5-10 minutes of your 
time. If you are interested in participating, please click the link below! All responses will remain 
anonymous.  
If you have any questions, please feel free to contact me: stilford@sandiego.edu 
Thank you so much! Your assistance in this study is greatly appreciated. 
